JPS60226880A - ６，９‐ジ置換‐９ｈ‐プリン誘導体、それらの製造法、およびそれらを含む医薬製剤 - Google Patents

６，９‐ジ置換‐９ｈ‐プリン誘導体、それらの製造法、およびそれらを含む医薬製剤

Info

Publication number
JPS60226880A
JPS60226880A JP60070739A JP7073985A JPS60226880A JP S60226880 A JPS60226880 A JP S60226880A JP 60070739 A JP60070739 A JP 60070739A JP 7073985 A JP7073985 A JP 7073985A JP S60226880 A JPS60226880 A JP S60226880A
Authority
JP
Japan
Prior art keywords
purine
formula
hydrogen
compound
fluorobencyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60070739A
Other languages
English (en)
Japanese (ja)
Inventor
ジエームス　レロイ　ケリイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS60226880A publication Critical patent/JPS60226880A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60070739A 1984-04-04 1985-04-03 ６，９‐ジ置換‐９ｈ‐プリン誘導体、それらの製造法、およびそれらを含む医薬製剤 Pending JPS60226880A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848408615A GB8408615D0 (en) 1984-04-04 1984-04-04 Heterocyclic compounds
GB8408615 1984-04-04

Publications (1)

Publication Number Publication Date
JPS60226880A true JPS60226880A (ja) 1985-11-12

Family

ID=10559131

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60070739A Pending JPS60226880A (ja) 1984-04-04 1985-04-03 ６，９‐ジ置換‐９ｈ‐プリン誘導体、それらの製造法、およびそれらを含む医薬製剤

Country Status (14)

Country Link
EP (1) EP0157637A3 ( )
JP (1) JPS60226880A ( )
AU (1) AU4081185A ( )
DD (1) DD233843A5 ( )
DK (1) DK147285A ( )
ES (3) ES8606348A1 ( )
FI (1) FI851351L ( )
GB (1) GB8408615D0 ( )
GR (1) GR850838B ( )
HU (1) HUT37429A ( )
IL (1) IL74803A0 ( )
PL (1) PL252743A1 ( )
ZA (1) ZA852534B ( )
ZW (1) ZW6785A1 ( )

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
EP0363320A3 (de) * 1988-10-06 1991-11-21 Ciba-Geigy Ag Substituierte 9H-Purine
US5166209A (en) * 1989-04-21 1992-11-24 Burroughs Wellcome Co. Pharmacologically active compounds
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5240937A (en) * 1990-04-20 1993-08-31 Burroughs Wellcome Co. Pharmaceutically active triazolopyridine compounds
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
ATE243697T1 (de) * 1995-12-08 2003-07-15 Pfizer Substitutierte heterozyclische derivate als crf antagonisten
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6648453B2 (en) 1997-07-15 2003-11-18 Silverbrook Research Pty Ltd Ink jet printhead chip with predetermined micro-electromechanical systems height
US20230279006A1 (en) * 2020-07-08 2023-09-07 Klotho Therapeutics, Inc. Novel compounds and methods for increasing klotho gene expression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846426A (en) * 1971-03-03 1974-11-05 Int Minerals & Chem Corp 6-amino-9-(substituted benzyl) purines and their n{11 oxides
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
GB1547214A (en) * 1977-08-09 1979-06-06 Merck & Co Inc Purine derivatives
US4189485A (en) * 1977-08-23 1980-02-19 Takeda Chemical Industries, Ltd. Purine derivatives
US4900826A (en) * 1981-09-24 1990-02-13 Kohjin Co., Ltd. Process for preparing N6,9-disubstituted adenine

Also Published As

Publication number Publication date
ZA852534B (en) 1986-11-26
EP0157637A2 (en) 1985-10-09
GB8408615D0 (en) 1984-05-16
ES541948A0 (es) 1986-04-16
ES8802051A1 (es) 1987-03-01
HUT37429A (en) 1985-12-28
EP0157637A3 (en) 1986-11-05
ZW6785A1 (en) 1986-11-12
ES550466A0 (es) 1987-03-01
AU4081185A (en) 1985-10-10
DK147285D0 (da) 1985-04-01
IL74803A0 (en) 1985-07-31
FI851351A0 (fi) 1985-04-03
DK147285A (da) 1985-10-05
GR850838B ( ) 1985-11-25
ES8802052A1 (es) 1987-03-01
PL252743A1 (en) 1986-09-09
ES8606348A1 (es) 1986-04-16
FI851351L (fi) 1985-10-05
DD233843A5 (de) 1986-03-12
ES550467A0 (es) 1987-03-01

Similar Documents

Publication Publication Date Title
ES2202827T3 (es) Pirrolo(2,3-d)pirimidinas y su uso como inhibidores de la tirosina kinasa.
ES2334998T3 (es) Derivado de 2-oxo-1-pirrolidina y sus usos farmaceuticos.
DE69818831T2 (de) Indolderivate als mcp-1 rezeptor antagonisten
DE60101479T2 (de) Betacarbolinderivate als phosphodiesterase-inhibitoren
ES2551325T3 (es) Compuestos orgánicos
ES2203615T3 (es) Nucleosidos terapeuticos.
US20080096903A1 (en) Sulfamoyl-containing derivatives and uses thereof
AU2023248127A1 (en) Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
BRPI0808746B1 (pt) Derivado de purinila como modulador do canal de potássio, composição farmacêutica, e, uso de um derivado de purinila.
CA2740391A1 (en) Organic compounds
TW201904942A (zh) 經取代５-氰基吲哚化合物及其用途
CA2699607A1 (en) Polo-like kinase inhibitors
JPH10507171A (ja) Ｐｎｐインヒビターとしてのプリンおよびグアニン化合物
JPS60226880A (ja) ６，９‐ジ置換‐９ｈ‐プリン誘導体、それらの製造法、およびそれらを含む医薬製剤
WO2015085844A1 (zh) 作为抗病毒剂的咪唑衍生物及其制药用途
CA3089159A1 (en) Pyrazolo[1,5-a][1,3,5]triazine-2-amine derivative, preparation method therefor and medical use thereof
JP2010505747A (ja) Ａ２ａアデノシンレセプタの選択的アンタゴニスト
JP3224542B2 (ja) 新規なアデノシン誘導体，その製造方法およびそれを含有する医薬組成物
KR20230118137A (ko) 안드로겐 수용체 및 포스포디에스테라아제 이중 억제제로서의신규 화합물
DE69031337T2 (de) 9-substituierte-8-unsubstituierte-9-deazaguanine
EP3402798B1 (en) Compounds antagonizing a3 adenosine receptor, method for preparing them, and medical-use thereof
KR100559526B1 (ko) 항염증작용과 근육이완작용을 갖는 콜히친 및 치오콜히친유도체들
EP0361831A1 (en) Antiviral nucleoside combination
JP2001503382A (ja) アデノシン誘導体
JP7305658B2 (ja) 抗ｒｓｖ活性を有するシクロアルキル置換ピラゾロピリミジン